The National Institutes of Health (NIH) has announced the availability of a government-owned invention for licensing, aimed at speeding up the commercialization of research funded by the government to benefit public health. This invention involves analogues of N-Lactoyl-Phenylalanine (Lac-Phe), which could serve as appetite suppressants and help treat obesity and related diseases. It is currently in the preclinical development stage and is open for licensing under U.S. patent law. Interested parties can contact Malabika Ghosh at the NIH for licensing details.
Simple Explanation
The government has a new medicine that might help people not feel hungry and could stop kids from getting too big; they want to share it with companies to make it useful for people soon.